Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection

Weill Medical College of Cornell University, New York

Columbia University, New York

Maryland Digestive Disease Research, Laurel

McGuire VA Medical Center, Richmond

Liver Institute of Virginia Bon Secours Health System, Newport News

Duke University, Durham

NW Georgia Research Institute, Marietta

University of Alabama Birmingham, Birmingham

Gastroenterology Associates, PA, Jackson

Northwest Indiana Center for Clinical Research, Valparaiso

Henry Ford Health System, Detroit

Mayo Clinic, Rochester

St. Louis University, St Louis

University of Texas Southwestern Medical Center at Dallas, Dallas

Baylor College of Medicine, Houston

Alamo Medical Research, San Antonio

University of Colorado, Aurora

South Denver Gastroenterology, Englewood

University of Arizona, Tucson

Scripps Clinic Torrey Pines, La Jolla

Research and Education inc., San Diego

Hawaii Medical Center, Honolulu

University of Connecticut Health Center, Farmingtom

Yale University School of Medicine, New Haven

Tulane University Hospital, New Orleans